Gordon Jewett

Gordon_Jewett_3x2

Assistant Professor, Neuromuscular Neurologist, University of Calgary

Director, University of Calgary Neuromuscular and EMG Fellowship Program


Email Gordon

Research Interests: Amyotrophic lateral sclerosis, neuromuscular disease, wearable sensors, machine learning, artificial intelligence

Google Scholar profile
ResearchGate profile
ORCiD profile
Twitter profile

Biography

Dr. Gordon Jewett is an Assistant Professor and Neuromuscular Neurologist at the University of Calgary, and Director, University of Calgary Neuromuscular and EMG Fellowship Program.

Dr. Jewett studied software engineering before completing his medical school at the University of Calgary in 2016. He became a Fellow of the Royal College of Physicians of Canada in 2021 after completing his adult neurology residency in Calgary. As a resident he was inspired by the complexity of the peripheral nervous system and the challenges in diagnosis and treatment of neuromuscular disease.

HeĀ completed a 2-year clinical and research fellowship in neuromuscular neurology with the strong clinical group at the University of Calgary. His research work will include completion of a master of neuroscience supervised by Dr. Lawrence Korngut and Dr. Joon Lee. His thesis is focused on development of novel disease biomarkers in amyotrophic lateral sclerosis (ALS), based on wearable sensors and machine learning. His research is generously funded by ALS Canada and the Canadian Institutes of Health Research (CIHR).

At every opportunity he escapes the city to explore the Rocky Mountains by ski, foot or bike with his two young daughters and partner.

 

Read Dr. Jewett’s Early-Career Blog!


Recent Publications

Hodgkinson V, Lounsberry J, Mā€™Dahoma S, Russell A, Jewett GAE, et al. The Canadian Neuromuscular Disease Registry 2010ā€“2019: A Decade of Facilitating Clinical Research Through a Nationwide, Pan-Neuromuscular Disease Registry. Journal of Neuromuscular Diseases. 2021; 8(1):53ā€“61. PMID: 32925088

MacLean, D, Beland, B, Jewett, GAE, Bartolini, L, Campbell, DJT, Varma, M et al.. Management Approaches to Intraluminal Thrombi in Acutely Symptomatic Carotid Stenosis. Can J Neurol Sci. 2024. 1-27 PMID:39592265

Dimmick, HL, Jewett, G, Korngut, LW, Ferber, R. Longitudinal relationships between free-living activities, fatigue, and symptom severity in myasthenia gravis using cohort and individualized models. Muscle Nerve. 2025.71 (1)33-42 PMID:39473433

Beland, B, Perera, T, Lee, A, Greenfield, J, Korngut, L, Jewett, G et al.. No sex-based differences in odds of starting or time to treatment of generalized myasthenia gravis: A single center cohort study. Muscle Nerve. 2024.70 (4)774-781 PMID:39054840

Jewett, G, Beland, B, Khayambashi, S, Silverstein, S, Donkervoort, S, Bƶnnemann, CG et al.. Recessive Pathogenic GMPPB Variants Cause a Childhood Onset Myasthenic Syndrome Responsive to Pyridostigmine. Can J Neurol Sci. 2024.51 (4)595-597 PMID:37681231

Perera, T, Khayambashi, S, Jewett, G, Hahn, C, McCulloch, S, Joseph, JT et al.. Plasmapheresis for Treatment of Light Chain Amyloidosis Related Myopathy. Can J Neurol Sci. 2024.51 (3)432-434 PMID:37009747

Ganesh, A, Beland, B, Jewett, GAE, Campbell, DJT, Varma, M, Singh, RJ et al.. Physician Approaches to Antithrombotic Therapies for Recently Symptomatic Carotid Stenosis. Can J Neurol Sci. 2024.51 (2)210-219 PMID:36803592

Jewett, G, Khayambashi, S, Frost, GS, Beland, B, Lee, A, Hodgkinson, V et al.. Diagnostic criteria in amyotrophic lateral sclerosis: Time for a change. Muscle Nerve. 2022.66 (6)E34-E35 PMID:36116127

Jewett, G, Khayambashi, S, Frost, GS, Beland, B, Lee, A, Hodgkinson, V et al.. Gold Coast criteria expand clinical trial eligibility in amyotrophic lateral sclerosis. Muscle Nerve. 2022.66 (4)397-403 PMID:35673968

Roberts, JI, Jewett, GAE, Tellier, R, Couillard, P, Peters, S. Twice Negative PCR in a Patient With Herpes Simplex Virus Type 1 (HSV-1) Encephalitis. Neurohospitalist. 2021.11 (1)66-70 PMID:33868561

Krett, JD, Jewett, GAE, Elton-Lacasse, C, Fonseca, K, Hahn, C, Au, S et al.. Hemorrhagic encephalopathy associated with COVID-19. J Neuroimmunol. 2020.346 577326 PMID:32683185

See more on PubMed